University of Washington has established RNA sequencing technology developer Split Biosciences, which has raised $1.2m in seed funding from unnamed investors.
Split Biosciences, a US-based single-cell analysis technology spinout of University of Washington, has raised $1.2m from undisclosed investors.
Split Biosciences has developed single-cell RNA sequencing technology, called Split-seq, that is based on research by Charlie Roco and Alex Rosenberg, two researchers in the lab of synthetic biology professor Georg Seelig.
The technology enables single-cell sequencing without the need to first separate all cells in a given sample, such as a biopsy of a tumour.
Roco told Geekwire: “In recent years, single-cell RNA-sequencing (scRNA-seq) has seen explosive growth both within academia and pharmaceutical companies. However, despite the widespread adoption of scRNA-seq in basic research and discovery, high costs and low throughput have limited its uses for many applications.”
